692 related articles for article (PubMed ID: 30577415)
1. Diet-Independent Correlations between Bacteria and Dysfunction of Gut, Adipose Tissue, and Liver: A Comprehensive Microbiota Analysis in Feces and Mucosa of the Ileum and Colon in Obese Mice with NAFLD.
Gart E; Souto Lima E; Schuren F; de Ruiter CGF; Attema J; Verschuren L; Keijer J; Salic K; Morrison MC; Kleemann R
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577415
[TBL] [Abstract][Full Text] [Related]
2. Heat-Inactivated
Morrison MC; Gart E; Duyvenvoorde WV; Snabel J; Nielsen MJ; Leeming DJ; Menke A; Kleemann R
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216439
[TBL] [Abstract][Full Text] [Related]
3. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
Wang P; Wang J; Li D; Ke W; Chen F; Hu X
J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
[TBL] [Abstract][Full Text] [Related]
4. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG
World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981
[TBL] [Abstract][Full Text] [Related]
5. Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High-Fat Diet Determine Non-Alcoholic Fatty Liver Disease Development in Germ-Free Mice.
Porras D; Nistal E; Martínez-Flórez S; Olcoz JL; Jover R; Jorquera F; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Mol Nutr Food Res; 2019 Apr; 63(8):e1800930. PubMed ID: 30680920
[TBL] [Abstract][Full Text] [Related]
6. Spinach consumption ameliorates the gut microbiota and dislipaemia in rats with diet-induced non-alcoholic fatty liver disease (NAFLD).
Elvira-Torales LI; Periago MJ; González-Barrio R; Hidalgo N; Navarro-González I; Gómez-Gallego C; Masuero D; Soini E; Vrhovsek U; García-Alonso FJ
Food Funct; 2019 Apr; 10(4):2148-2160. PubMed ID: 30938723
[TBL] [Abstract][Full Text] [Related]
7. Diammonium Glycyrrhizinate Protects against Nonalcoholic Fatty Liver Disease in Mice through Modulation of Gut Microbiota and Restoration of Intestinal Barrier.
Li Y; Liu T; Yan C; Xie R; Guo Z; Wang S; Zhang Y; Li Z; Wang B; Cao H
Mol Pharm; 2018 Sep; 15(9):3860-3870. PubMed ID: 30036479
[TBL] [Abstract][Full Text] [Related]
8. Lingguizhugan decoction attenuates diet-induced obesity and hepatosteatosis
Liu MT; Huang YJ; Zhang TY; Tan LB; Lu XF; Qin J
World J Gastroenterol; 2019 Jul; 25(27):3590-3606. PubMed ID: 31367159
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
10. Microbiota, Obesity and NAFLD.
Lau LHS; Wong SH
Adv Exp Med Biol; 2018; 1061():111-125. PubMed ID: 29956210
[TBL] [Abstract][Full Text] [Related]
11. Dietary Uncoupling of Gut Microbiota and Energy Harvesting from Obesity and Glucose Tolerance in Mice.
Dalby MJ; Ross AW; Walker AW; Morgan PJ
Cell Rep; 2017 Nov; 21(6):1521-1533. PubMed ID: 29117558
[TBL] [Abstract][Full Text] [Related]
12. Western diet-induced mouse model of non-alcoholic fatty liver disease associated with metabolic outcomes: Features of gut microbiome-liver-adipose tissue axis.
Romualdo GR; Valente LC; Sprocatti AC; Bacil GP; de Souza IP; Rodrigues J; Rodrigues MAM; Vinken M; Cogliati B; Barbisan LF
Nutrition; 2022; 103-104():111836. PubMed ID: 36202025
[TBL] [Abstract][Full Text] [Related]
13. Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese Mice.
de Sant'Ana LP; Ribeiro DJS; Martins AMA; Dos Santos FN; Corrêa R; Almeida RDN; Eberlin MN; Maurice CF; Magalhães KG
Front Immunol; 2019; 10():2926. PubMed ID: 31998283
[TBL] [Abstract][Full Text] [Related]
14. Walnut green husk polysaccharides prevent obesity, chronic inflammatory responses, nonalcoholic fatty liver disease and colonic tissue damage in high-fat diet fed rats.
Wang G; Yang X; Wang J; Zhong D; Zhang R; Zhang Y; Feng L; Zhang Y
Int J Biol Macromol; 2021 Jul; 182():879-898. PubMed ID: 33857511
[TBL] [Abstract][Full Text] [Related]
15. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats.
Zhang Y; Tang K; Deng Y; Chen R; Liang S; Xie H; He Y; Chen Y; Yang Q
Biomed Pharmacother; 2018 Jun; 102():1025-1036. PubMed ID: 29710519
[TBL] [Abstract][Full Text] [Related]
16. Deficiency of intestinal mucin-2 protects mice from diet-induced fatty liver disease and obesity.
Hartmann P; Seebauer CT; Mazagova M; Horvath A; Wang L; Llorente C; Varki NM; Brandl K; Ho SB; Schnabl B
Am J Physiol Gastrointest Liver Physiol; 2016 Mar; 310(5):G310-22. PubMed ID: 26702135
[TBL] [Abstract][Full Text] [Related]
17. Impact of short-term overfeeding of saturated or unsaturated fat or sugars on the gut microbiota in relation to liver fat in obese and overweight adults.
Jian C; Luukkonen P; Sädevirta S; Yki-Järvinen H; Salonen A
Clin Nutr; 2021 Jan; 40(1):207-216. PubMed ID: 32536582
[TBL] [Abstract][Full Text] [Related]
18. Colonic aberrant crypt formation accompanies an increase of opportunistic pathogenic bacteria in C57BL/6 mice fed a high-fat diet.
Zeng H; Ishaq SL; Liu Z; Bukowski MR
J Nutr Biochem; 2018 Apr; 54():18-27. PubMed ID: 29223827
[TBL] [Abstract][Full Text] [Related]
19. The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD.
Soderborg TK; Clark SE; Mulligan CE; Janssen RC; Babcock L; Ir D; Young B; Krebs N; Lemas DJ; Johnson LK; Weir T; Lenz LL; Frank DN; Hernandez TL; Kuhn KA; D'Alessandro A; Barbour LA; El Kasmi KC; Friedman JE
Nat Commun; 2018 Oct; 9(1):4462. PubMed ID: 30367045
[TBL] [Abstract][Full Text] [Related]
20. Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects.
Yun Y; Kim HN; Lee EJ; Ryu S; Chang Y; Shin H; Kim HL; Kim TH; Yoo K; Kim HY
PLoS One; 2019; 14(3):e0213692. PubMed ID: 30870486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
